Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Oct 18, 2016 (10 years ago)

HCG (Chorionic Gonadotropin Lyopholized)

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Subpotent Drug: due to failed potency results of 74% (spec. 80-125%).

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

HCG (Chorionic Gonadotropin Lyopholized) II, 1000 unit vial, Rx only, Prepared by Town & Country, Compounding & Consultation Services, 106 Prospect St - 1st FL, Ridgewood, NJ 07459

Recalling firm
Town and Country Compounding and Consultation Services, LLC
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0436-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Town and Country Compounding and Consultation Services, LLC

All 2016 recalls

Other wrong potency / content recalls from 2016

All wrong potency / content recalls
Class III · Low risk

Aripiprazole Tablets

Superpotent Drug; out of specification results for assay (manufacturer)

Terminated Wrong potency / content The Harvard Drug Group NDC 0904-6509-04 D-0692-2017